WEGOVY 2 mg/mL
semaglutide · INJECTION, SOLUTION · Novo Nordisk Pharmaceutical Industries, LP
WEGOVY is a injection, solution containing semaglutide at 2 mg/mL, taken subcutaneous. Manufactured by Novo Nordisk Pharmaceutical Industries, LP.
Key Facts
- Brand Name
- WEGOVY
- Generic Name
- semaglutide
- NDC Code (Product)
0169-1610- Manufacturer
- Novo Nordisk Pharmaceutical Industries, LP
- Strength
- 2 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA215256
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 06/05/2021
Recall History
Cardinal Health Inc.
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Novo Nordisk Inc.
Presence of Particulate Matter: Hair was found in a prefilled syringe
Novo Nordisk Inc.
Presence of Particulate Matter: Hair was found in a prefilled syringe
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is WEGOVY used for?
WEGOVY contains semaglutide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is WEGOVY a controlled substance?
WEGOVY is not classified as a controlled substance by the DEA.
What is the generic name for WEGOVY?
The generic name for WEGOVY is semaglutide. There are 4 other brand versions of semaglutide.
What is the NDC code for WEGOVY 2 mg/mL?
The NDC (National Drug Code) for WEGOVY 2 mg/mL is 0169-1610, listed by Novo Nordisk Pharmaceutical Industries, LP.